Physician profile
Benjamin K Hendricks
NPI 1295180461
$202,354.18
in general payments reported to CMS, 2019-2025
10 companies · $2,087 in 2025
The $2,087 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $37K · 2024: $163K · 2025: $2,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $101K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $88K · Travel and Lodging: $9,835 · Food and Beverage: $3,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $101,480.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $87,960.00 |
| Travel and Lodging | $9,835.06 |
| Food and Beverage | $3,079.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $197,032.58 | 2023-2025 | Stealthstation S8 Platform, Mazor X System, Cd Horizon Spinal System |
| Alphatec Spine, INC | $3,983.43 | 2023-2025 | Other - Miscellaneous |
| Abbott Laboratories | $845.25 | 2024-2025 | Infinity, Eterna, Proclaim |
| Integra Lifesciences Corporation | $171.40 | 2023 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Hakim |
| Stryker Corporation | $127.66 | 2023 | Duramatrix, Universal Neuro 3, Na |
| Biotissue Holdings INC. | $56.05 | 2025 | |
| Ceribell, INC. | $55.42 | 2023 | Ceribell Rapid Response Eeg |
| Cornerstone Medical Associates, INC. | $42.92 | 2025 | |
| Ebi, LLC | $20.45 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Abbvie INC. | $19.02 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Hendricks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.